Psilocybin vs MDMA — Shrooms vs Molly Guide for the DMV
Psilocybin vs MDMA: distinct pharmacology, distinct risks. Psilocybin is a classic psychedelic acting on 5-HT2A receptors. MDMA is an empathogen that releases serotonin, dopamine, and norepinephrine. MDMA carries neurotoxicity risk at high or frequent doses and the 3-month rule applies. MAPS PTSD trials, Johns Hopkins depression trials, and harm reduction for the DMV community.